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RÉSUMÉ 
Comparaison des habitudes de prescription de médicaments psychotropes dans des 
cliniques de psychiatrie adulte et de psychogériatrie 
Afin de pouvoir comparer l'utilisation de médicaments psychotropes et non psychotropes, la 
proportion des nouveaux et celle des anciens antidépresseurs ou antipsychotiques, ce travail a 
eu pour but d'étudier les prescriptions médicamenteuses dans deux groupes de patients 
hospitalisés, l'un en milieu psychiatrique adulte (de 18 à 64 ans), l'autre en milieu 
psychogériatrique (plus de 64 ans). 
Lors d'un jour de référence en Mai 2000, toutes les prescriptions médicamenteuses dans deux 
hôpitaux psychiatriques universitaires abritant l'un une population adulte, l'autre gériatrique, 
ont été relevées chez tous les patients. Le coût financier total par patient a été comparé en 
tenant compte de la proportion des médicaments non psychotropes. 
La médication de 61 patients adultes et de 82 patients gériatriques a ainsi été analysée. Le 
nombre moyen de médicaments non psychotropes par patient était plus élevé dans la 
population âgée (p< 0.001), ce qui se reflète également par une prescription totale de 
médicaments par patient en moyenne plus élevée dans cette population (p<0.001). 
L'utilisation de benzodiazépines était inférieure dans la population psychogériatrique 
(p<0.001), même si l'on y additionne celle en association avec les antidépresseurs (p<0.001). 
Le coût financier du traitement pharmacologique quotidien d'un patient adulte était 
significativement inférieur à celui d'un patient gériatrique dont la comédication somatique 
est nécessairement plus importante ( 9.3 ± 7.2 CHF/patient contre 14.1±9.5 CHF/patient) 
(p<0.009). 
En conclusion, cette étude confirme l'importance des habitudes locales dans la prescription 
médicamenteuse par les médecins, à l'exception de l'utilisation des benzodiazépines pour 
lesquelles les psychogériâtres semblent moins favorables. 
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ABSTRACT 
Background and objective 
Drug prescriptions were studied in two samples of inpatients, which differed by their age (patients 18 
to 64 y vs elderly patients > 64 y), in order to compare the use of psychotropic and non-psychiatrie 
drugs, and the proportion of newer vs classical antidepressants or antipsychotics. 
Methods 
Drug prescription was recorded on a reference day in May 2000 in two hospitals, which differed by the 
age categories of the patients who were admitted. The total costs per patient were compared, as well 
as the proportion of those due to a somatic medication. 
Resu/ts 
The prescriptions of 61 adult patients and of 82 psychogeriatric patients were assessed. The mean 
number of prescribed somatic drugs per patient was higher in elderly patients (p < 0.001 ), which was 
again reflected in a higher mean number of ail drugs jointly (p < 0.001 ). Prescription of 
benzodiazepines was lower in elderly patients than in the adult patients (p < 0.001 ), also of that in 
addition to antidepressants (p < 0.001). The pharmacological treatment of adult patients (9.3 ± 7.2 
Swiss Francs/patient) was significantly less expensive than that of the psychogeriatric patients ( 14.1 ± 
9.5 Swiss Francs/patient) (p = 0.009), who had a higher need for somatic comedications. 
Conclusions 
This survey confirms the large impact of local traditions on the prescription habits of clinicians, with the 
exception of the prescription of benzodiazepines, for which psychiatrists of psychogeriatric patients 
seem to be more reluctant. 
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1nm111uction 
There have been recently several studies performed in order to understand the factors which influence 
the prescription of psychotropic drugs 1-4 . Characteristics of the health care system, physician 
management style, physician specialty and training, public attitudes, drug cost and availability, patients 
preferences, local tradition education, marketing and formulary have been reported to have some 
impact on the prescription habits 5-9. On the other hand, patients characteristics have been described 
have less impact on the prescription 5' 7. 
Whereas there is some data on prescribing habits of psychotropic drugs for elderly patients 10-13 , a 
direct comparison with younger adults has, to our knowledge, not been published until now. A direct 
comparison between a geriatric and an adult sample would allow ruling out the bias of sociocultural 
factors. The comparison between two samples of a same health care system could avoid, furthermore, 
educational issues. 
The population of elderly patients is characterized by multiple comorbidities and is, subsequently, 
often polymedicated. This is, among others, associated with an increased risk for pharmacodynamie 
and pharmacokinetic interactions. Though, the indications of psychotropic drugs in elderly patients are 
usually identical to those of youhger adults, the contraindications have to be evaluated more carefully 
in elderly subjects 11 · 14· 15 . Moreover, some drugs are specifically used for conditions exclusively seen 
in the geriatric population, e.g. cognitive enhancers. 
The arrivai of new drugs, especially newer antidepressants, antipsychotics and mood stabilizers, has 
been expected to have achieved rapid acceptance by prescribers because of enhanced safety 
profiles, relative to those observed with older drugs 1' 16 . This may be particularly true for the 
prescription in elderly patients. 
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The aim of the present study was to compare the prescriptions in a sample of inpatients aged 18 to 64 
y and a sample of elderly inpatients aged > 64 y, treated in two hospitals, which are located on the 
same site, and have a common medical educational program. 
Methods 
The present study was realized as part of the AMSP project (Arzneimittelsicherheit in der Psychiatrie= 
drug safety in psychiatry), which is a program for continuous assessmèntof adverse drug reactions in 
'psychiatrie inpatients under naturalistic conditions of routine clinical treatment. The methodology has 
been described elsewhere 17-19 . Currently, more than 35 German and Swiss sites are participating. 
Data on drug use in the participating hospitals are based on two reference days per year. Ali drugs 
given on a reference day are recorded along with age, sex, and diagnosis (ICD-10) for all patients 
under surveillance. The daily dosage is also recorded. 
The data of the present study are drawn out of the reference day of Mai 2000 in the psychiatrie 
hospital and the psychogeriatric hospital of the University of Lausanne, Switzerland. Whereas, the two 
hospitals are affiliated to different departments (Department of Psychogeriatry and Department of 
Adult Psychiatry), bath are located on the same site sharing most paramedical and logistical facilities. 
The medical postgraduate education and the continued medical education are commonly organized by 
bath departments. During their residence training numerous physicians have accomplished stages in 
both clinics. 
The psychogeriatric hospital of Lausanne is a 88-bed hospital for psychiatrie patients aged 65 years 
and more. The mean hospitalization duration is 60 days, and the nurse/bed ratio 0.8. The psychiatrie 
hospital for adult patients has 98 beds. The mean hospitalization duration is 20 days and the 
nurse/bed ratio is 0.95. 
The objective of the present study was to compare the average pre·scription of psychotropic and 
nonpsychotropic drugs. The percentage of patients without psychotropics, the proportion of new · 
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antidepressants versus aider antidepressants, and of atypical antipsychotics versus classical 
antipsychotics were analyzed. 
Definition of substance classes: 
"Newer antidepressants" were defined as the selective serotonin reuptake inhibitors paroxetine, 
sertraline, fluoxetine, citalopram and fluvoxamine as well as mirtazapine, reboxetine, nefazodone and 
moclobemide. At the lime of the reference day, reboxetine was not yet introduced in Switzerland. 
The group of "atypical antipsychotics" included clozapine, olanzapine, risperidone and· amisulpride. 
Analyses 
Bath hospitals were compared with respect to the mean prescription of psychotropic and 
nonpsychotropic drugs, the proportion atypical antipsychotics/all antipsychotics, the proportion newer 
antidepressants/all antidepressants. Furthermore, the utilization of anticholinergics was compared 
between patients receiving conventional antipsychotics with those receiving atypical antipsychotics 
only. Finally the total costs per patient were compared, as well as the proportion of costs of somatic 
treatment. 
Cast calculations 
Costs per mg of each prescribed product were calculated on the basis of the price of the smallest 
package available on the Swiss market published in the Swiss Compendium of Drugs 20 . Costs were 
calculated in Swiss Francs. The change of one Swiss Franc was 0.68 Euros and 0.68 US Dollars on 
November 1, 2002. The cost per mg was multiplied per prescribed milligrams for each prescription. 
Statistics 
The Students t-test was used for comparison of continuous variables, and the Chi-square test for 
categorical variables. For ail of the statistical tests, the significance level was set at p < 0:05. The data 
were analyzed using the SPSS for Windows program, version 11. O. 
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ResuHs 
The prescriptions of 61 adult patients and of 82 psychogeriatric patients were assessed. The mean 
ages were 41.6 ± 12.4 y (range 20 - 64 y) and 78.4 ± 8.2 y (range 65 - 95 y) respectiveiy. The 
proportion of women was significantly higher (p = 0.001) in the psychogeriatric sample (63/82; 76.8 %) 
than in adult patients (29/61; 47.5 %). 
The distribution of the adult patients regarding their primary ICD-10 diagnosis was: Mental and 
behavioral disorders due to psychoactive substance use (F10): 5 (8.2 %); schizophrenia, schizotypal 
and delusional disorders (F20): 29 (47.5 %); mood disorders (F30): 19 (39.4 %); behavioral 
syndromes associated with physiological disturbances and physical factors (F50): 1 (1.6 %); disorders 
of adult personality and behavior (F60): 7 (3.3 %). The distribution of the elderly patients was: Organic 
mental disorders (FO): 33 (40.2 %); mental and behavioral disorders due to psychoactive substance 
use (F10): 3 (3.7 %); schizophrenia, schizotypal and delusional disorders (F20): 10 (12.2 %); mood 
disorders (F30): 30 (37.8 %); neurotic, stress-related and somatoform disorders (F40): 4 (4.9 %); 
disorders of adult personality and behavior (F60): 1 (1.2 %). 
Prescribed drugs per patient 
Table 1 shows the number of prescribed drugs per patient. Whereas there was no significant 
difference with regard to psychotropic drugs, the mean number of prescribed somalie drugs per patient 
was higher in elderly patients (p < 0.001 ), which was again reflected in a higher mean number of ail 
drugs jointly (p < 0.001 ). 
Benzodiazepine prescriptions 
There was a significant difference (p < 0.001) between the two groups with regard to the prescription 
of benzodiazepines. Of the 61 adult patients, 20 (32.8 %) had no benzodiazepine prescribed, 34 (55.7 
%) received one and 7 (11.5 %) received two benzodiazepines. ln the sample of elderly patients, the 
distribution was: 64 (78.0 %) subjects with no benzodiazepines and 18 (32.0 %) subjects with one 
benzodiazepine prescribed. , 
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Prescription of antipsychotics 
Thirty-seven adult and 53 psychogeriatric patients had received antipsychotics. Among the patients 
receiving antipsychotics in the adult sample 19 (51.4 %) had a conventional drug, 12 (32.4 %) 
received an atypical antipsychotic, and 6 (16.2 %) were treated with a combination of drugs from bath 
classes. Among the psychogeriatric patients receiving antipsychotics 37 (69.8 %) were treated with a 
conventional drug, 13 (24.5 %) had an atypical antipsychotic, and 3 (5.7 %) a combination of both. 
The difference did not reach statistical significance. 
Antidepressant prescriptions 
The prescription practices of antidepressants are shown in Table 2. No difference was found with 
regard to the utilization of newer antidepressants, bath clinics largely preferring new generation drugs. 
ln up to two thirds of the patients in bath clinics, antidepressants were prescribed in patients, who had 
a primary diagnosis other than depression or anxlety, i.e. the labeled indications for these drugs. 
None of the patients of bath samples had received more than one antidepressant. Only 8 patients in 
the elderly group, who had a primary diagnosis of depression, did not receive any antidepressant at 
the survey day, whereas ail patients in the adult group were treated with antidepressants. 
Significant differences between the two samples were found relating to the combination of 
antidepressants with benzodiazepines. The use of benzodiazepines in addition to antidepressants was 
more frequent in adult patients (p = 0.001 ). 
A logistic regression was carried out to compare the prescription of benzodiazepines (dependent 
variable) between the two clinics controlling for sex, offlabel use of the antidepressant, and 
concomitant prescription of an antipsychotic. Overall, 69.3% of the patients were correctly classified. 
While the effects of sex and the concomitant prescription of an antipsychotic drug were not significant, 
the odds ratio of receiving a concomitant prescription of a benzodiazepine was 6.70 (90%CI: 2.16 -
20.75) for patients from the psychogeriatric wards. Also, receiving the antidepressant for an offlabel 
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indication (i.e. not presenting a depression or an anxiety disorder) increased the risk of concomitantly 
receiving a benzodiazepine by 3.50 (90%Cl:1.16-10.30). 
Costs of drug treatment 
When comparing the two samples regarding the costs of ail prescribed drugs per patient, the 
pharmacological treatment of the psychogeriatric patients was significantly more expensive than that 
of a duit patients, with 14.1 ± 9.5 Swiss Francs/patient and 9.3 ± 7 .2 Swiss Francs/patient respectively 
(p = 0.009) (Table 3). Whereas the costs per patient did not differ between the two groups with regard 
to psychotropic drugs and subclasses of psychotropic drugs (antidepressants, antipsychotics), there 
was a significant difference as to the costs for somatic drugs (p < 0.001 ). 
Discussion 
The present study compared prescription habits between a psychogeriatric hospital and a psychiatrie 
hospital for adult patients. Whereas elderly patients received, as could be expected, at average more 
drugs per person, this difference was due to the higher utilization of somatic drugs, the frequency of 
psychotropic drugs not differing between the two samples. These figures were again found when 
comparing the cost data. The higher average cost per patient for the psychogeriatric group was due to 
the higher prescription rate of somatic drugs. 
The most important difference with regard to the prescription habits of psychotropic drugs was the 
higher propensity of prescribers in the hospital for adult patients to use benzodiazepines. This effect 
remained statistically significant even after being controlle.d for sex, out-label prescription and 
concomitant antipsychotic drug prescription. One can hypothesize, that benzodiazepines may have 
been avoided in elderly patients in order to prevent cognitive side effects or myorelaxation associated 
falls. lnterestingly, and independent from the age class of the patients, receiving an antidepressant 
without presenting a labeled indication for this drug (i.e. a depression or an anxiety disorder), 
increased the risk of having a concomifènt benzodiazepine prescribed. One could cynically speculate 
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that in a certain proportion of these "off-label patients" the antidepressant-benzodiazepine combination 
represents rather an indicator of pharmacotherapeutic helplessness than the result of a rational 
therapeutic strategy. As no patient records data on prescription rationales are available for the present 
analyses, this hypothesis has to remain speculative. 
Treatment guidelines usually recommend psychopharmacological monotherapy 21 ' 22 . The present 
study finally confirms previous observations that psychotropic polypharmacy is rather the rule than the 
exception in psychiatrie inpatient populations, as well in adult as also in elderly patients. We found a 
mean number of 2. 7 ± 1.3 drugs for adult patients and 2.4 ± 1.3 drugs for elderly patients. The 
prescription frequencies in our survey were similar to those of many other studies, which showed that, 
habitually, an average of 2 or 3 psychotropic drugs are prescribed for psychiatrie patients, both 
according to data collected cross-sectional or longitudinal surveys 22-27 . 
Possible. bias of the survey may be due to its cross-sectional nature and the differences with regard to 
the proportions of diagnostic subgroups. A further limitation, which could have influenced the results, 
was that only the primary diagnosis was retained. No data on comorbid disorders, which could have 
influenced the choice of medication, were available. 
Patients characteristics have previously been described to be taken less into account by doctors when 
choosing a treatment, while regional preferences and traditions often result being more important 5' 7 . 
One of the strength of this survey may be the comparison of two hospitals, which share the same 
pregraduate and postgraduate training, and sharing consequently a same diagnostic and 
pharmacotherapeutic tradition. This is revealed by the comparable diffusion of newer drugs, i.e. 
atypical antipsychotics and antidepressants of the newer generations. ln contrast to what has been 
found in other studies 5' 7, we found patients characteristics to affect doctors decisions, but only with 
regard to the choice of sedative or anxiolytic medication. 
9 
lt is also of interest that during our study carried out in 2000, depressive patients were only 
exceptionally treated with tricyclic antidepressants . This is in line with the trend observed in Ontario of 
an increasing prescription rate of SS Ris in elderly patients while that of tricyclics decreased between 
1993 - 1997 28 . ln contrast, among the prescribed antipsychotics, the proportion of classical 
antipsychotics prescribed was still higher than that of atypical. However, this is not in contradiction with 
a study in veterans suffering from psychosis and treated with antipsychotics. There was a clear 
increase of the prescription of atypical antipsychotics between 1998 - 2000, but the part of 
conventional antipsychotics was still close to 40 % 29 
ln conclusion, our study confirms the large impact of local traditions on the prescription habits of 
psychiatrists, with the exception of the prescription of benzodiazepines, for which psychiatrists of 
psychogeriatric patients seem to be more reluctant. 
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Table 1. Number of prescribed drugs per patient 
Number of drugs/patient 
Number of psychotropic drugs/patient 
Number of somatic drugs/patient 
Adult patients (n = 61) 
mean . SD range 
3.6 1.8 0 - 8 
2.7 1.3 0 - 7 
0.9 1.2 0 - 5 
Psychogeriatric patients (n = 82) Statistics p 
mean SD range 
5.9 2.6 1-11 t = -6.037 p < Q.001 
2.5 1.2 0-5 t = 1.109 p = 0.53 
3.4 2.3 0-9 t = -4.4 p < 0.001 
Table 2. Antidepressant prescrîptions 
Adult patients (n Psychogeriatric p 
= 61) patients (n = 82) 
Antidepressants (n = 76) 
Tricyclics 2 6.7 % 1 2.2 % p = 0.704 
Newer AD 28 93.3 % 45 97.8 % 
Off label use AD (n = 76) 
Depression/ Anxiety 10 33.3 % 14 46.7 % p = 0.814 
Other' 20 66.7 % 24 52.2 % 
AD in depressed Patients (n = 39) 
Newer Antidepressant 9 90.0 % 20 69.0 % p = 0.148 
Tricyclics 1 10.0 % 1 3.4 % 
No antidepressant 0 0.0 % 8 27.6 % 
Benzodiazepines in AD treated patients (n = 76) 
Yes 21 70.0 % 13 28.3 % p = 0.001 
No 9 30.0 % 33 71.1 % 
Antipsychotics in AD treated patients (n = 76) 
Yes 13 43.3 % 29 63.0 % p = 0.146 
No 17 56.7 % 17 27.0 % 
Table 3. Costs of drug treatment* 
Total costs of drugs per patient 
Costs somatic drugs per patient 
treated with somatic drugs 
Costs psychotropic drugs per patient 
Costs antipsychotics per patient 
treated with antipsychotics 
Costs antidepressants per patient 
treated with antidepressants 
*in Swiss Francs; cf Table 2 for the 
number of patients in the subgroups 
Adult patients 
(n = 61) 
mean SD 
9.3 7.2 
3.4 3.1 
7.8 6.8 
5.8 5.8 
5.1 2.9 
Psychogeriatric 
patients (n = 82) 
mean SD 
14.1 9.5 
6.8 6.4 
8.2 7.7 
4.1 6.4 
5.9 3.3 
Statistics 
t=-3.313 p=.001 
t=-2.636 p=.010 
t=0.292 p=.771 
t=1.317 p=.191 
t=-1.072 p=0.287 
